文献速递创伤与烧伤重症综合管理与镇静镇痛

无机多聚磷酸与核酸抑制剂在创伤患者血浆中减弱体外凝血酶生成

INHIBITORS OF INORGANIC POLYPHOSPHATE AND NUCLEIC ACIDS ATTENUATE IN VITRO THROMBIN GENERATION IN PLASMA FROM TRAUMA PATIENTS.
PubMed 文献 · Shock · 2024-03-25
一句话结论创伤患者血浆中多聚磷酸抑制剂MPI 8和UHRA-8(50 μg/mL)可减弱体外凝血酶生成,但作用弱于对照。

该研究采用校准自动凝血酶生成图(CAT)检测56例创伤患者和39例对照血浆在加入多聚磷酸拮抗剂MPI 8和UHRA-8(50 μg/mL)前后的凝血酶生成参数。创伤患者基线峰值身高(PH)高于对照(182.9 [121.0, 255.2] nM vs 120.5 [62.1, 174.8] nM,P < 0.001)。MPI 8和UHRA-8均延长创伤和对照的滞后时间(LT)和达峰时间(ttPeak),UHRA-8还降低PH,所有P < 0.05。抑制剂对对照的效应(ΔLT和ΔttPeak)大于创伤患者(P < 0.001)。作者认为多聚磷酸抑制减弱凝血酶生成,但在创伤中程度较轻,提示多聚磷酸参与创伤后凝血酶生成加速。

要点

  • 创伤患者基线凝血酶生成峰值身高(PH)高于对照:182.9 [121.0, 255.2] nM vs 120.5 [62.1, 174.8] nM,P < 0.001。
  • MPI 8(50 μg/mL)延长创伤患者LT至7.20 [5.88, 8.75] min(基线6.46 [5.45, 8.93] min,P = 0.020),延长ttPeak至11.28 [8.96, 13.14] min(基线11.00 [8.95, 12.94] min,P = 0.029)。
  • UHRA-8(50 μg/mL)延长创伤患者LT至9.09 [7.45, 11.33] min、ttPeak至14.02 [11.78, 17.08] min,降低PH至117.4 [74.5, 178.6] nM(基线分别为6.46 [5.45, 8.93] min、11.00 [8.95, 12.94] min、182.9 [121.0, 255.2] nM),均P < 0.001。
  • 抑制剂对对照的ΔLT和ΔttPeak大于创伤患者(P < 0.001),提示多聚磷酸在创伤后凝血酶生成加速中起作用但贡献相对较小。

适用人群与场景

  • 56例创伤患者和39例对照的血浆样本,体外实验。

处置流程与药物剂量

  • MPI 8和UHRA-8均以50 μg/mL浓度加入血浆,采用校准自动凝血酶生成图(CAT)检测凝血酶生成。

研究设计与关键结果

  • 研究类型为体外实验,样本为56例创伤患者和39例对照血浆。
  • 创伤患者基线PH高于对照:182.9 [121.0, 255.2] nM vs 120.5 [62.1, 174.8] nM,P < 0.001。
  • MPI 8(50 μg/mL)延长创伤患者LT(7.20 [5.88, 8.75] min vs 6.46 [5.45, 8.93] min,P = 0.020)和ttPeak(11.28 [8.96, 13.14] min vs 11.00 [8.95, 12.94] min,P = 0.029)。
  • MPI 8(50 μg/mL)延长对照LT(7.67 [6.67, 10.50] min vs 6.33 [5.33, 8.00] min,P < 0.001)和ttPeak(13.33 [11.67, 15.33] min vs 11.67 [10.33, 13.33] min,P < 0.001)。
  • UHRA-8(50 μg/mL)延长创伤患者LT至9.09 [7.45, 11.33] min、ttPeak至14.02 [11.78, 17.08] min,降低PH至117.4 [74.5, 178.6] nM(基线分别为6.46 [5.45, 8.93] min、11.00 [8.95, 12.94] min、182.9 [121.0, 255.2] nM),均P < 0.001。
  • UHRA-8(50 μg/mL)延长对照LT至9.83 [8.00, 12.33] min、ttPeak至16.67 [14.33, 20.00] min,降低PH至55.3 [30.2, 95.9] nM(基线分别为6.33 [5.33, 8.00] min、11.67 [10.33, 13.33] min、120.5 [62.1, 174.8] nM),均P < 0.001。
  • 抑制剂对对照的ΔLT和ΔttPeak均大于创伤患者,P < 0.001。

证据类型、等级与局限

  • 证据类型:体外实验。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为多聚磷酸抑制减弱凝血酶生成,但在创伤患者中程度较轻,提示多聚磷酸参与创伤后凝血酶生成加速。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Inorganic polyphosphate (polyP) is a procoagulant polyanion. We assessed the impact of polyP inhibition on thrombin generation after trauma using the novel polyP antagonists, macromolecular polyanion inhibitor 8 (MPI 8), and universal heparin reversal agent 8 (UHRA-8). Methods: Plasma thrombin generation (calibrated automated thrombogram, CAT), in 56 trauma patients and 39 controls +/- MPI 8 and UHRA-8 (50 μg/mL), was expressed as lag time (LT, minutes), peak height (PH, nM), and time to peak (ttPeak, minutes), with change in LT (ΔLT) and change in ttPeak (ΔttPeak) quantified. Results expressed in median and quartiles [Q1, Q3], Wilcoxon matched-pairs testing, P < 0.05 significant. Results: Trauma patients had greater baseline PH than controls (182.9 [121.0, 255.2]; 120.5 [62.1, 174.8], P < 0.001). MPI 8 treatment prolonged LT and ttPeak in trauma (7.20 [5.88, 8.75]; 6.46 [5.45, 8.93], P = 0.020; 11.28 [8.96, 13.14]; 11.00 [8.95, 12.94], P = 0.029) and controls (7.67 [6.67, 10.50]; 6.33 [5.33, 8.00], P < 0.001; 13.33 [11.67, 15.33]; 11.67 [10.33, 13.33], P < 0.001). UHRA-8 treatment prolonged LT and ttPeak and decreased PH in trauma (9.09 [7.45, 11.33]; 6.46 [5.45, 8.93]; 14.02 [11.78, 17.08]; 11.00 [8.95, 12.94]; 117.4 [74.5, 178.6]; 182.9 [121.0, 255.2]) and controls (9.83 [8.00, 12.33]; 6.33 [5.33, 8.00]; 16.67 [14.33, 20.00]; 11.67 [10.33, 13.33]; 55.3 [30.2, 95.9]; 120.5 [62.1, 174.8]), all P < 0.001. Inhibitor effects were greater for controls (greater ΔLT and ΔttPeak for both inhibitors, P < 0.001). Conclusion: PolyP inhibition attenuates thrombin generation, though to a lesser degree in trauma than in controls, suggesting that polyP contributes to accelerated thrombin generation after trauma.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. MacArthur TA, Goswami J, Navarro SM, et al. INHIBITORS OF INORGANIC POLYPHOSPHATE AND NUCLEIC ACIDS ATTENUATE IN VITRO THROMBIN GENERATION IN PLASMA FROM TRAUMA PATIENTS. Shock. 2024. PMID: 38662595. doi:10.1097/SHK.0000000000002362

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。